🔎 Trials Near Me

Home › Obesity › North Carolina › Havelock

Pag-aaral pangklinika para sa Obesity sa Havelock, NC

Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Havelock. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3
  • West Clinical Research, Morehead City · 15 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3
  • West Clinical Research, Morehead City · 15 mi ang layo
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2
  • Centricity Research - Morehead city /ID# 283264, Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Nagre-recruitPhase 3
  • Lucas Research, Inc, Morehead City · 15 mi ang layo
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3
  • Carteret Medical Group, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3
  • West Clinical Research, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Lucas Research, Inc, Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3
  • AURORA-2 Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3
  • AURORA-1 Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • Centricity Research Morehead City Multispeciality, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2
  • Lucas Research, Inc., Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • ACCOMPLISH-2 Research Site, Morehead City · 15 mi ang layo
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Lucas Research, Inc, Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3
  • Centricity Research Morehead City Specialty, Morehead City · 15 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Pag-aaral para sa Obesity sa ibang lungsod

Iba pang pag-aaral sa Havelock

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.